Last reviewed · How we verify
RSV preF Protein 50 mcg — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
RSV preF Protein 50 mcg (RSV preF Protein 50 mcg) — Janssen Vaccines & Prevention B.V..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| RSV preF Protein 50 mcg TARGET | RSV preF Protein 50 mcg | Janssen Vaccines & Prevention B.V. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- RSV preF Protein 50 mcg CI watch — RSS
- RSV preF Protein 50 mcg CI watch — Atom
- RSV preF Protein 50 mcg CI watch — JSON
- RSV preF Protein 50 mcg alone — RSS
Cite this brief
Drug Landscape (2026). RSV preF Protein 50 mcg — Competitive Intelligence Brief. https://druglandscape.com/ci/rsv-pref-protein-50-mcg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab